Funded Startups in Costa Mesa
Among the 15 most recent funded startups listed for Costa Mesa, the largest disclosed round is Regents Capital Corporation’s $133M round dated 2026-04-28,…
Among the 15 most recent funded startups listed for Costa Mesa, the largest disclosed round is Regents Capital Corporation’s $133M round dated 2026-04-28, which dwarfs the next-largest disclosed amount visible here ($100M for TOCA Football on 2024-10-10). The disclosed amounts also show a wide spread: several deals cluster in the single-digit millions (e.g., Gold Flora $7M on 2024-08-28; LunarCrush $5M on 2023-07-12; Givsum $2M on 2021-11-05), while a few are dramatically higher ($68M for Neurolens on 2022-09-12; $12M for Veritas Aortic Solutions on 2026-06-01).
Time-wise, activity is front-loaded in the latest portion of the window: 5 of the 15 rounds have dates in 2026 (from 2026-01-05 Orange Twist through 2026-06-24 Los Sundays Tequila). Stage/label information is also uneven: 6 of 15 entries are either “undisclosed” or “Series Unknown” in the listing (with “undisclosed” amounts for Los Sundays Tequila on 2026-06-24, Orange Twist on 2026-01-05, and Enginius.ai on 2025-09-16), while other identifiable stages recur across healthcare/biotech (e.g., Veritas Aortic Solutions “Seed” in 2026-06-01; Neurolens “Venture - Series Unknown” in 2022-09-12; Navix Health Inc “Pre-Seed” in 2022-09-01).
Most recent rounds
15 shownRelated listings
Frequently asked
What’s the largest disclosed round in this Costa Mesa list, and how does it compare to other disclosed amounts?
Regents Capital Corporation’s $133M (2026-04-28) is the clear outlier; the next-highest disclosed amount in the table is TOCA Football’s $100M (2024-10-10), with other disclosed rounds largely below that level (e.g., Neurolens $68M on 2022-09-12; Veritas Aortic Solutions $12M on 2026-06-01).
How much of the funding activity shown is concentrated in the most recent dates?
The latest year dominates the view: 5 of 15 rounds have 2026 dates (2026-01-05 through 2026-06-24). That concentration is visible in the mid-year cluster including Regents Capital Corporation ($133M, 2026-04-28), Veritas Aortic Solutions ($12M, 2026-06-01), and Real Messenger ($4M, 2026-06-08).
Are there notable outliers in disclosed amounts aside from the top end?
Yes on the lower end: the only explicitly smallest disclosed amounts are $2M for both Cadi (2022-06-04) and Givsum (2021-11-05). In contrast to those $2M entries, the disclosed amounts include multiple much larger rounds such as Neurolens $68M (2022-09-12) and TOCA Football $100M (2024-10-10).
Which stage labels appear often enough to suggest a pattern, and how do they relate to the disclosed-size range?
“Seed” shows up twice with Veritas Aortic Solutions ($12M, 2026-06-01) and Enginius.ai (2025-09-16, undisclosed amount), while “Venture - Series Unknown” appears twice as well (Utelogy $680K, 2025-09-15; Neurolens $68M, 2022-09-12). That pair spans a wide disclosed range from $680K to $68M, indicating that the label alone doesn’t predict deal size in this slice.
Does the list skew toward any particular sector, and do those sector entries cluster around the same time?
Healthcare/biotech is concentrated in multiple entries across different years: Veritas Aortic Solutions (Health Care, $12M on 2026-06-01), Navix Health Inc (Health Care, undisclosed on 2022-09-01), and Neurolens (Biotechnology, $68M on 2022-09-12). In contrast, several non-health categories are represented by single entries such as TOCA Football (Sports, $100M on 2024-10-10) and LunarCrush (AI, $5M on 2023-07-12).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.